<DOC>
	<DOCNO>NCT00004806</DOCNO>
	<brief_summary>OBJECTIVES : Evaluate efficacy safety lipid-mediated transfer cystic fibrosis transmembrane conductance regulator gene nasal epithelium patient cystic fibrosis .</brief_summary>
	<brief_title>Phase I Study Liposome-Mediated Gene Transfer Patients With Cystic Fibrosis</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Cystic fibrosis transmembrane conductance regulator ( CFTR ) gene complexed lipid administer intranasally right inferior turbinate . Lipid without CFTR administer left nostril control . Cohorts 3 patient give successively low dos CFTR , dose complexed 500 microgram lipid . Patients follow day 2-12 , 15 , 21 , every 3-4 day 3 week , every 2-3 week 10 week , every 3 month thereafter .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Cystic fibrosis ( CF ) , i.e . : Sweat chloride great 60 mEq/L Clinical manifestation CF Homozygous delta F508 mutation prefer Compound heterozygotes F508 mutation pancreatic insufficiency eligible FEV1 great 40 % predict PO2 least 60 mm Hg room air No acute recurrent sinusitis No obstructive nasal polyposis No pneumothorax hemoptysis , e.g. , 250 mL blood within 24hour period , within past year No unstable lung disease worsen pulmonary symptom , arterial blood gas , pulmonary function test within 2 week prior entry No pulmonary exacerbation within 4 week prior entry Prior/Concurrent Therapy At least 2 month since participation clinical study At least 2 month since DNase At least 4 month since corticosteroid Patient Characteristics Cardiac : No severe cardiac disease Other : No severe organ system disease , e.g. , juveniletype diabetes mellitus No pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>cardiovascular respiratory disease</keyword>
	<keyword>cystic fibrosis</keyword>
	<keyword>genetic disease dysmorphic syndrome</keyword>
	<keyword>rare disease</keyword>
</DOC>